BridgeMD
Efficacy and safety trial of intraperitoneal furosemide in patients on peritoneal dialysis
EU CTIS ID: 2024-519356-87-00
What this study is testing
To study the clinical response to furosemide administered intraperitoneally compared to orally on the hydration status of stable patients in a PD unit.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patients on treatment with a daily dose equal to or higher than 120 mg of stable oral furosemide during previous fifteen days .
- Patients over 18 years of age
- Clinically stable patients in PD technique
- Patients with a normofunctioning PD catheter
- Patients with residual diuresis greater than 500ml per day
- Patients who have undergone a peritoneal equilibrium test in the previous three months
You likely can't join if
- Allergy to furosemide
- Inability of the patient or caregiver to administer intraperitoneal therapy at home
- Need to modify the rest of the oral diuretic treatment at the time of inclusion in the study and during follow-up
See the full eligibility criteria
- Patients on treatment with a daily dose equal to or higher than 120 mg of stable oral furosemide during previous fifteen days .
- Patients over 18 years of age
- Clinically stable patients in PD technique
- Patients with a normofunctioning PD catheter
- Patients with residual diuresis greater than 500ml per day
- Patients who have undergone a peritoneal equilibrium test in the previous three months
- Patients who wish to participate and who sign the informed consent form
- Allergy to furosemide
- Inability of the patient or caregiver to administer intraperitoneal therapy at home
- Need to modify the rest of the oral diuretic treatment at the time of inclusion in the study and during follow-up
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.